题名

巴金森失智症與路易氏體失智症

并列篇名

Parkinson's Disease with Dementia and Dementia with Lewy Bodies

作者

黃楚雲(Chu-Yun Huang)；黃錦章(Chin-Chang Huang)

关键词

巴金森失智症 ； 路易氏體失智症 ； 神經影像 ； 病理 ； 生物標記 ； 診斷 ； 治療 ； Parkinson's disease with dementia ； Dementia with Lewy bodies ； Neuroimages ； Pathology ； Biomarkers ； Diagnosis ； Treatment

期刊名称

應用心理研究

卷期/出版年月

55期（2012 / 09 / 01）

页次

59 - 98

内容语文

繁體中文
中文摘要

巴金森失智症和路易氏體失智症臨床特徵非常相似，包括認知功能障礙、行為異常、自律神經症狀和巴金森症候群。這2種疾病最大的差異在於臨床症狀出現的時間不同，現在以1年來區分；即認知障礙出現於錐體外徑症狀1年以後，則屬巴金森失智症，相反的如果認知障礙出現於錐體外徑症狀1年內或認知障礙出現早於錐體外徑症狀則為路易氏體失智症。病理學上兩者相同都有路易氏體積聚於皮質、邊緣系統、新皮質地區和腦幹。路易氏體失智症臨床診斷包括三大核心特徵如巴金森氏症、認知功能波動和視幻覺，以及三項建議特點，如（1）快速動眼期睡眠行為障礙、（2）嚴重的抗精神藥物敏感、（3）基底核之多巴胺載體影像吸收降低等。巴金森失智症雖然尚缺統一之共識基準，但最近已有建議之診斷標準。由於神經影像學和分子生物學的進步，對路易氏體失智症和巴金森失智症的致病機轉更加瞭解。病理變化上這兩種疾病也可伴隨著阿茲海默的病理變化如老人性斑塊，此現象使臨床症狀更具多樣性。此二種疾病的藥物治療與一般巴金森氏病和阿茲海默氏病的治療有很大的不同，需要臨床醫師更小心的鑑別診斷和使用藥物。
英文摘要

Patients with Parkinson's disease with dementia (PDD) or dementia with Lewy bodies (DLB) have similar clinical manifestations including cognitive impairment, behavior disorders, autonomic dysfunction, and parkinsonian features. The difference between these two disorders is based on the one year rule: PDD is diagnosed while the onset of dementia occurs 12 months or more after the onset of parkinsonism and DLB is diagnosed if cognitive impairment precedes or follows the parkinsonian features within 12 months. Both share the same pathological features including Lewy bodies in the cortex, limbic system, neocortical area and brainstem. The diagnostic criteria of DLB include three core features of parkinsonism, fluctuation of cognition, and visual hallucination. Three additional suggestive features include REM sleep behavior disorder, neuroleptic sensitivity, and an abnormal dopamine transporter scan. Although there is no formal consensus criteria for diagnosing PDD, a new clinical diagnostic criteria has been proposed by the Movement Disorder Society. With recent advances in neuroimaging and molecular biological studies, understanding of the pathogenetic mechanisms has become possible. In addition to the Lewy bodies in these two disorders, senile plaques with amyloid appear in both. With the combination of Lewy bodies and senile plaques deposition, the clinical features of PDD and DLB prove more complex, which leads to diagnostic challenges between these two disorders. Finally, the therapeutic approaches to PDD and DLB are different from the treatments for Alzheimer's disease and Parkinson's disease.
主题分类 社會科學 > 心理學
参考文献
  1. Parkinson, J. (Sir James) (1817). An essay on the shaking palsy. London, England: Whittingham and Rowland for Sherwood, Neely, and Jones.
  2. Aarsland, D.,Andersen, K.,Larsen, J. P.,Lolk, A.,Kragh-Sørensen, P.(2003).Prevalence and characteristics of dementia in Parkinson disease: An 8 year prospective study.Archives of Neurology,60(3),387-392.
  3. Aarsland, D.,Andersen, K.,Larsen, J. P.,Lolk, A.,Nielsen, H.,Kragh-Sørensen, P.(2001).Risk of dementia in Parkinson's disease: A community-based, prospective study.Neurology,56(6),730-736.
  4. Aarsland, D.,Andersen, K.,Larsen, J. P.,Perry, R.,Wentzel-Larsen, T.,Lolk, A.,Kragh-Sørensen, P.(2004).The rate of cognitive decline in Parkinson disease.Archives of Neurology,61(12),1903-1911.
  5. Aarsland, D.,Ballard, C. G.,Halliday, G.(2004).Are Parkinson's disease with dementia and dementia with Lewy bodies the same entity?.Journal Geriatric Psychiatry Neurology,17(3),137-145.
  6. Aarsland, D.,Larsen, J. P.,Cummins, J. L.,Laake, K.(1999).Prevalence and clinical correlates of psychotic symptoms in Parkinson disease: A community-based study.Archives of Neurology,56(5),595-601.
  7. Aarsland, D.,Perry, R.,Larsen, J. P.,McKeith, I. G.,O''Brien, J. T.,Perry, E. K.,Ballard, C. G.(2005).Neuroleptic sensitivity in Parkinson's disease and parkinsonian dementias.Journal Clinical Psychiatry,66(5),633-637.
  8. Ballard, C. G.,Aarsland, D.,McKeith, I.,O''Brien, J.,Gray, A.,Cormack, F.,Tovee, M.(2002).Fluctuations in attention: PD dementia vs. DLB with Parkinsonism.Neurology,59(11),1714-1720.
  9. Barber, R.,Ballard, C.,McKeith, I. G.,Gholkar, A.,O''Brien, J. T.(2000).MRI volumetric study of dementia with Lewy bodies: A comparison with AD and vascular dementia.Neurology,54(6),1304-1309.
  10. Barber, R.,Gholkar, A.,Scheltens, P.,Ballard, C.,McKeith, I. G.,O''Brien, J. T.(1999).Medial temporal lobe atrophy on MRI in dementia with Lewy bodies.Neurology,52(6),1153-1158.
  11. Barber, R.,Scheltens, P.,Gholkar, A.,Ballard, C.,McKeith, I.,Ince, P.(1999).White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer's disease, vascular dementia, and normal aging.Journal of Neurology Neurosurgery and Psychiatry,67(1),66-72.
  12. Barker, W. W.,Luis, C. A.,Kashuba, A.,Luis, M.,Harwood, D. G.,Loewenstein, D.,Duara, R.(2002).Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the State of Florida Brain Bank.Alzheimer Disease & Associated Disorders,16(4),203-212.
  13. Boeve, B. F.,Ferman, T. J.,Silber, M. H.,Ferman, T. J.(2003).Sleep disturbances in dementia with Lewy bodies involve more than REM sleep behavior disorder.Neurology,60,A79.
  14. Boeve, B. F.,Silber, M. H.,Ferman, T. J.(2004).REM sleep behavior disorder in Parkinson's disease and dementia with Lewy bodies.Journal Geriatric Psychiatry Neurology,17,146-157.
  15. Boeve, B. F.,Silber, M. H.,Parisi, J. E.,Dickson, D. W.,Ferman, T. J.,Benarroch, E. E.,Mahowald, M. W.(2003).Synucleinopathy pathology and REM sleep behavior disorder plus dementia or Parkinsonism.Neurology,61(1),40-45.
  16. Bonini, N. M.,Giasson, B. I.(2005).Snaring the function of alpha-synuclein.Cell,123(3),359-361.
  17. Braak, H.,Del Tredici, K.,Rub, U.,De Vos, R. A.,Jansen Steur, E. N.,Braak, E.(2003).Staging of brain pathology related to sporadic Parkinson's disease.Neurobiology Aging,24(2),197-211.
  18. Braak, H.,Rub, U.,Jansen Steur, E. N.,Del Tredici, K.,De Vos, R. A.(2005).Cognitive status correlates with neuropathologic stage in Parkinson's disease.Neurology,64(8),1404-1410.
  19. Bradshaw, J. M.,Saling, M.,Anderson, V.,Hopwood, M.,Brodtmann, A.(2006).Higher cortical deficits influence attentional processing in dementia with Lewy bodies, relative to patients with dementia of the Alzheimer's type and controls.Journal of Neurology Neurosurgery and Psychiatry,77(10),1129-1135.
  20. Burn, D. J.(2006).Cortical Lewy body disease and Parkinson's disease dementia.Current Opinion Neurology,19(6),572-579.
  21. Burn, D. J.,Rowan, E. N.,Minnett, T.,Sanders, J.,Myint, P.,Richardson, J.,McKeith, I. G.(2003).Extrapyramidal features in Parkinson's disease with and without dementia and dementia with Lewy bodies: A cross-sectional comparative study.Movement Disorder,18(8),884-889.
  22. Cahn-Weiner, D. A.,Williams, K.,Grace, J.,Tremont, G.,Weatervelt, H.,Stern, R. A.(2003).Discrimination of dementia with Lewy bodies from Alzheimer's disease and Parkinson's disease using the clook drawing test.Cognition Behavior Neurology,16(2),85-92.
  23. Caparros-Lefebvre, D.,Pechevx, N.,Petit, V.,Duhamel, A.,Petit, H.(1995).Which factors predict cognitive decline in Parkinson's disease?.Journal of Neurology Neurosurgery and Psychiatry,58(1),51-55.
  24. Chandra, S.,Gallardo, G.,Fernandez-Chacon, R.,Schlüter, O. M.,Südhof, T. C.(2005).Alpha-synuclein cooperates with CSP alpha in preventing neurodegeneration.Cell,123(3),383-396.
  25. Chang, C. C.,Liu, J. S.,Chang, Y. Y.,Chang, W. N.,Chen, S. S.,Lee, C. H.(2008).(99m)Tc-ethyl cysteinate dimer brain SPECT findings in early stage of dementia with Lewy bodies and Parkinson's disease patients: A correlation with neuropsychological tests.European Journal of Neurology,15(1),61-65.
  26. Chiu, M. J.,Chen, T. F.,Yi, P. K.,Hua, M. S.,Tang, L. Y.(2006).Behavioral and psychologic symptoms in different types of dementia.Journal of Formosan Medical Association,105(7),556-562.
  27. Chui, H. C.,Mortimer, J. A.,Slager, U.,Zarow, C.,Bondareff, W.,Webster, D. D.(1986).Pathologic correlates of dementia in Parkinson's disease.Archives of Neurology,43(10),991-995.
  28. Cole, N. B.,Murphy, D. D.,Grider, T.,Rueter, S.,Brasaemle, D.,Nussbaum, R. L.(2002).Lipid droplet binding and oligomerization properties of the Parkinson's disease protein alpha-synuclein.Journal of Biological Chemistry,277(8),6344-6352.
  29. Collerton, D.,Burn, D.,McKeith, I.,Obrien, J.(2003).Systematic review and meta-analysis show that dementia with Lewy bodies is a visual-perceptual and attentional-executive dementia.Dementia Geriatric Cognitive Disorder,16(4),229-237.
  30. Costa, A.,Pappe, A.,Dell''Agnello, G.,Carlesimo, G. A.,Murri, L.,Bonuccelli, U.,Caltagirone, C.(2003).Dopaminergic modulation of visual-spatial working memory in Parkinson's disease.Dementia Geriatric Cognitive Disorder,15(2),55-66.
  31. Cousins, D. A.,Burton, E. J.,Burn, D.,Gholkar, A.,McKeith, I. G.,O''Brien, J. T.(2003).Atrophy of the putamen in dementia with Lewy bodies but not Alzheimer's disease: An MRI study.Neurology,61(9),1191-1195.
  32. Donnemiller, E.,Heilmann, J.,Wenning, G. K.,Berger, W.,Decristoforo, C.,Moncayo, R.,Ransmayr, G.(1997).Brain perfusion scintigraphy with 99mTc-HMPAO or 99mTc-ECD and 123I-bata-CIT single-photon emission tomography in dementia of the Alzheimer-type and diffuse Lewy body disease.European Journal Nuclear Medicine,24(3),320-325.
  33. Dubois, B.,Burn, D.,Goetz, C.,Aarsland, D.,Brown, R. G.,Broe, G. A.,Emre, M.(2007).Diagnostic procedures for Parkinson's disease dementia: Recommendations for the movement disorder society take force.Movement Disorder,22(16),2314-2324.
  34. Edwards, K.,Royall, D.,Hershey, L.,Lichter, P.,Hake, A.,Farlow, M.,Johnson, S.(2007).Efficacy and safety of galantamine in patients with dementia with Lewy bodies: A 24-week open-label study.Dementia Geriatric Cognitive Disorder,23(6),401-405.
  35. Emre, M.,Aarsland, D.,Brown, R.,Burn, D. J.,Duyckaerts, C.,Mizuno, Y.,Dubois, B.(2007).Clinical diagnostic criteria for dementia associated with Parkinson's disease.Movement disorder,22(12),1689-1707.
  36. Ferman, T. J.,Smith, G. E.,Boeve, B. F.,Ivnik, R. J.,Petersen, R. C.,Knopman, D.,Dickson, D. W.(2004).DLB fluctuations: Specific features that reliably differentiate DLB from AD and normal aging.Neurology,62(2),181-187.
  37. Fernandez, H. H.,Trieschmann, M. E.,Burke, M. A.,Friedman, J. H.(2002).Quetiapine for psychosis in Parkinson's disease versus dementia with Lewy bodies.Journal Clinical Psychiatry,63(6),513-515.
  38. Fernandez, H. H.,Trieschmann, M. E.,Burke, M. A.,Jacques, C.,Friedman, J. H.(2003).Long-term outcome of quetiapine use for psychosis among Parkinsonian patients.Movement Disorder,18(5),510-514.
  39. Forsberg, A.,Engler, H.,Almkvist, O.,Blomquist, G.,Hagman, G.,Wall, A.,Nordberg, A.(2008).PET imaging of amyloid deposition in patients with mild cognitive impairment.Neurobiology Aging,29(10),1456-1465.
  40. Galvin, J. E.(2006).Cognitive change in Parkinson disease.Alzheimer Disease Association Disorder,20(4),302-310.
  41. Galvin, J. E.,Lee, V. C. M.,Trojanowski, J. Q.(2001).Synucleinopathies: Clinical and pathological implications.Archives Neurology,58(2),186-190.
  42. Galvin, J. E.,Pollack, J.,Morris, J. C.(2006).Clinical phenotype of Parkinson disease dementia.Neurology,67(9),1605-1611.
  43. Gaspar, P.,Gray, F.(1984).Dementia in idiopathic Parkinson's disease: A neuropathological study of 32 cases.Acta Neuropathological,64(1),43-52.
  44. George, J. M.,Jin, H.,Woods, W. S.,Clayton, D. F.(1995).Characterization of a novel protein regulated during the critical period for song learning in the zebra finch.Neuron,15(2),361-372.
  45. Gjerstad, M. D.,Aarsland, D.,Larsen, J. P.(2002).Development of daytime somnolence overtime in Parkinson's disease.Neurology,58(10),1544-1546.
  46. Han, H.,Weinreb, P. H.,Lansbury, P. T., Jr.(1995).The core Alzheimer's peptide NAC forms amyloid fibrils which seed and are seeded by beta-amyloid: Is NAC a common trigger or target in neurodegenerative disease?.Chemical Biology,2(3),163-169.
  47. Harding, A. J.,Broe, G. A.,Halliday, G. M.(2002).Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe.Brain,125(Pt2),391-403.
  48. Henderson, R.,Kurlan, R.,Kersun, J. M.,Como, P. G.(1992).Preliminary examination of the comorbidity of anxiety and depression in Parkinson's disease.Journal Neuropsychiatry Clinical Neuroscience,4(3),257-264.
  49. Higuchi, M.,Tashiro, M.,Arai, H.,Okamura, N.,Hara, S.,Higuchi, S.,Sasaki, H.(2000).Glucose hypometabolism and neuropathological correlates in brains of dementia with Lewy bodies.Experimental Neurology,162(2),247-256.
  50. Hsiao, I.-T.,Huang, C.-C.,Hsieh, C.-J.,Hsu, W.-C.,Wey, S.-P.,Yen, T.-C.,Lin, K.-J.(2012).Correlation of early-phase F-18 Florbetapir (AV-45/Amyvid) PET images to FDG images: Preliminary studies.European Journal of nuclear medicine and molecular imaging,39(4),613-620.
  51. Hu, X. S.,Okamura, N.,Arai, H.,Higuchi, M.,Matsui, T.,Tashiro, M.,Sasaki, H.(2000).18F-fluorodopa PET study of striatal dopamine uptake in the diagnosis of dementia with Lewy bodies.Neurology,55(10),1575-1577.
  52. Hughes, T. A.,Ross, H. F.,Musa, S.,Bhattacherjee, S.,Nathan, R. N.,Mindham, R. H.,Spokes, E. G.(2000).A 10-year study of the incidence and factors predicting dementia in Parkinson's disease.Neurology,54(8),1596-1602.
  53. Jakes, R.,Spillantini, M. G.,Goedert, M.(1994).Identification of two distinct synucleins from human brain.FEBS Letters,345(1),27-32.
  54. Janvin, C. C.,Larsen, J. P.,Salmon, D. P.,Galasko, D.,Hugdahl, K.,Aarsland, D.(2006).Cognitive profiles of individual patients with Parkinson's disease and dementia: Comparison with dementia with Lewy bodies and Alzheimer's disease.Movement Disorder,21(3),337-342.
  55. Ji, H.,Liu, Y. E.,Jia, T.,Wang, M.,Liu, J.,Xiao, G.,Shi, Y. E.(1997).Identification of a breast cancer-specific gene, BCSG1, by direct differential cDNA sequencing.Cancer Research,57(4),759-764.
  56. Johnson, D. K.,Morris, J. C.,Galvin, J. E.(2005).Verbal and visuospatial deficits in dementia with Lewy bodies.Neurology,65(8),1232-1238.
  57. Kenny, R. A.,Kalaria, R.,Ballard, C.(2002).Neurocardiovascular instability in cognitive impairment and dementia.Annals of the New York Academy Sciences,977,183-195.
  58. Kenny, R. A.,Shaw, F. E.,O''Brien, J. T.,Scheltens, P. H.,Kalaria, R.,Ballard, C.(2004).Carotid sinus syndrome is common in dementia with Lewy bodies and correlates with deep white matter lesions.Journal of Neurology Neurosurgery and Psychiatry,75(7),966-971.
  59. Klatka, L. A.,Louis, E. D.,Schiffer, R. B.(1996).Psychiatric features in diffuse Lewy body disease: A clinicopathologic study using Alzheimer's disease and Parkinson's disease comparison groups.Neurology,47(5),1148-1152.
  60. Klunk, W. E.,Engler, H.,Nordberg, A.,Wang, Y.,Blomqvist, G.,Holt, D. P.,Långström, B.(2004).Imaging brain amyloid in Alzheimer's disease with Pittsburgh compound-β.Annals of Neurology,55(3),306-319.
  61. Kosaka, K.(1990).Diffuse Lewy body disease in Japan.Journal of Neurology,237(3),197-204.
  62. Kosaka, K.,Matsushita, M.,Oyanagi, S.,Mehraein, P.(1980).A clinicopathological study of the Lewy body disease.Psychiatric Neurology Japanica,82(5),292-311.
  63. Kovari, E.,Gold, G.,Herrmann, F. R.,Canuto, A.,Hof, P. R.,Bouras, C.,Giannakopoulos, P.(2003).Lewy body densities in the entorhinal and anterior cingulated cortex predict cognitive deficits in Parkinson's disease.Acta Neuropathologica,106(1),83-88.
  64. Kuzis, G.,Sabe, L.,Tiberti, C.,Leiguarda, R.,Starkstein, S. E.(1997).Cognitive functions in major depression and Parkinson's disease.Archives of Neurology,54(8),982-986.
  65. Lavedan, C.,Leroy, E.,Dehejia, A.,Buchholtz, S.,Dutra, A.,Nussbaum, R. L.,Polymeropoulos, M. H.(1998).Identification, localization and characterization of the human gamma-synuclein gene.Human Genetics,103(1),106-112.
  66. Lee, W.-J.,Tsai, C.-F.,Wang, S.-J.,Fuh, J.-L.(2012).The association between cognitive impairment and neuropsychiatric symptoms in patients with Parkinson's disease dementia.International Psychogeriatrry,27,1-8.
  67. Lees, A. J.,Smith, E.(1983).Cognitive deficits in the early stages of Parkinson's disease.Brain,106(part 2),257-270.
  68. Levin, B. E.,Llabre, M. M.,Weiner, W. J.(1989).Cognitive impairments associated with early Parkinson's disease.Neurology,39(4),557-561.
  69. Lin, K. J.,Hsu, W. C.,Hsiao, I. T.,Wey, S. P.,Jin, L. W.,Skovronsky, D.,Kung, M. P.(2010).Whole body biodistribution and brain PET imaging with [18F] AV-45, a novel amyloid imaging agent-a pilot study.Nuclear Medicine Biology,37(4),497-508.
  70. Lippa, C. F.,Duda, J. E.,Grossman, M.,Hurtig, H. I.,Aarsland, D.,Boeve, B. F.,Wszolek, Z. K.(2007).DLB and PDD boundary issues: Diagnosis, treatment, molecular pathology, and biomarkers.Neurology,68(11),812-819.
  71. Litvan, I.,Goldman, J. G.,Tröster, A. I.,Schmand, B. A.,Weintraub, D.,Petersen, R. C.,Mollenhauer, B.,Adler, C. H.,Marder, K.,Williams-Gray, C. H.,Aarsland, D.,Kulisevsky, J.,Rodriguez-Oroz, M. C.,Burn, D. J.,Barker, R. A.,Emre, M.(2012).Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines.Mov Disord,27,349-56.
  72. Liu, C.-K.,Lai, C.-L.,Tai, C.-T.,Lin, R.-T.,Yen, Y.-Y.,Howng, S.-L.(1998).Incidence and subtypes of dementia in southern Taiwan impact of socio-demographic factors.Neurology,50(6),1572-1579.
  73. Louis, E. D.,Klatka, L. A.,Liu, Y.,Fahn, S.(1997).Comparison of extrapyramidal features in 31 pathologically confirmed cases of diffuse Lewy body disease and 34 pathologically confirmed cases of Parkinson's disease.Neurology,48(2),376-380.
  74. Martí, M. J.,Tolosa, E.,Campdelacreu, J.(2003).Clinical overview of the synucleinopathies.Movement Disorder,18(Suppl 6),S21-27.
  75. Mathis, C. A.,Backskai, B. J.,Kajdasz, S. T.,McLellan, M. E.,Frosch, M. P.,Hyman, B. T.,Klunk, W. E.(2002).A lipophilic thioflavin-T derivative for positron emission tomography (PET) imaging of amyloid in brain.Bioorganic&Medicinal Chemistry Letters,12(3),295-298.
  76. Matsui, H.,Udaka, F.,Miyoshi, T.,Hara, N.,Tamura, A.,Oda, M.,Kameyama, M.(2005).N-isopropyl-p-123I iodoamphetamine single photon emission computed tomography study of Parkinson's disease with dementia.International Medicine,44(10),1046-1050.
  77. McKeith, I. G.(2007).Dementia with Lewy Bodies and Parkinson's disease with dementia: Where two world collide.Practical Neurology,7(6),374-382.
  78. McKeith, I. G.(2000).Spectrum of Parkinson's disease, Parkinson's dementia, and Lewy body dementia.Neurologic Clinic,18(4),865-902.
  79. McKeith, I. G.,Ballard, C. G.,Perry, R. H.,Ince, P. G.,O''Brien, J. T.,Neill, D.,Perry, E. K.(2000).Prospective validation of consensus criteria for the diagnosis of dementia with Lewy bodies.Neurology,24(5),1050-1058.
  80. McKeith, I. G.,Dickson, D. W.,Lowe, J.,Emre, M.,O''Brien, J. T.,Feldman, H.,Yamada, M.(2005).Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium.Neurology,65(12),1863-1872.
  81. McKeith, I. G.,Fairbairn, A. F.,Perry, R. H.,Thompson, P.(1994).The clinical diagnosis and misdiagnosis of senile dementia of Lewy body type (SDLT).British Journal of Psychiatry,165(3),324-332.
  82. McKeith, I. G.,Galasko, D.,Kosaka, K.,Perry, E. K.,Dickson, D. W.,Hansen, L. A.,Perry, R. H.(1996).Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop.Neurology,47(5),1113-1124.
  83. McKeith, I. G.,Perry, R. H.,Fairbairn, A. F.,Jabeen, S.,Perry, E. K.(1992).Operational criteria for senile dementia of Lewy body type (SDLT).Psychological Medicine,22(4),911-922.
  84. McKeith, I. G.,Wesnes, K. A.,Perry, E.,Ferrara, R.(2004).Hallucinations predict attentional improvements with rivastigmine in dementia with lewy bodies.Dementia Geriatric Cognitive Disorder,18(1),94-100.
  85. McKeith, I.,Del Ser, T.,Spano, P.,Emre, M.,Wesnes, K.,Anand, R.,Spiegel, R.(2000).Efficacy of rivastigmine in dementia with Lewy bodies: A randomised, double-blind, placebo-controlled international study.Lancet,356(9247),2031-2036.
  86. McKeith, I.,Mintzer, J.,Aarsland, D.,Burn, D.,Chiu, H.,Cohen-Wansfield, J.,Reid, W.(2004).Dementia with Lewy bodies.Lancet Neurology,3(1),19-28.
  87. Meco, G.,Bonifati, V.,Cusimano, G.,Fabrizio, E.,Vanacore, N.(1990).Hallucinations in Parkinson disease: Neuropsychological study Ital.Journal of the Neurologic Sciences,11(4),373-379.
  88. Menza, M. A.,Robertson-Hoffman, D. E.,Bonapace, A. S.(1993).Parkinson's disease and anxiety: Comorbidity with depression.Biological Psychiatry,34(7),465-470.
  89. Molloy, S.,McKeith, I. G.,O''Brien, J. T.,Burn, D. J.(2005).The role of L-dopa in the management of dementia with Lewy bodies.Journal of Neurology Neurosurgery and Psychiatry,76(9),1200-1203.
  90. Monsch, A. U.,Bondi, M. W.,Butters, N.,Salmon, D. P.,Katzman, R.,Thal, L. J.(1992).Comparisons of verbal fluency tasks in the detection dementia of the alzheimer type.Arch Neurol,49(12),1253-1258.
  91. Mori, E.,Shimomura, T.,Fujimori, M.,Hirono, N.,Imamura, T.,Hashimoto, M.,Hanihara, T.(2000).Visuoperceptual impairment in dementia with Lewy bodies.Archives of Neurolgy,57(4),489-493.
  92. Mosimann, U. P.,Mather, G.,Wesnes, K. A.,O''Brien, J. T.,Burn, D. J.,McKeith, I. G.(2004).Visual perception in Parkinson disease dementia and dementia with Lewy bodies.Neurology,63(11),2091-2096.
  93. Murphy, D. D.,Rueter, S. M.,Trojanowski, J. Q.,Lee, V. M.(2000).Synucleins are developmentally expressed, and alpha-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons.Journal of the Neurologic Sciences,20(9),3214-3220.
  94. Ninkina, N. N.,Alimova-Kost, M. V.,Paterson, J. W.,Delaney, L.,Cohen, B. B.,Imreh, S.,Buchman, V. L.(1998).Organization, expression and polymorphism of the human persyn gene.Human Molecular Genetics,7(9),1417-1424.
  95. Okereke, C. S.,Kirby, L.,Kumar, D.,Cullen, E. I.,Pratt, R. D.,Hahne, W. A.(2004).Concurrent administration of donepezil HCl and L-dopa/carbidopa in patients with Parkinson's disease: Assessment of pharmacokinetic changes and safety following multiple oral doses.British Journal of Clinical Pharmacology,58(S1),41-49.
  96. Orskov, L.,Jakobsen, J.,Dupont, E.,De Fine Olivarius, B.,Christensen, N. J.(1987).Autonomic function in parkinsonian patients relates to duration of disease.Neurology,37(7),1173-1178.
  97. Owen, A. M.,Roberts, A. C.,Hodges, J. R.,Polkey, C. E.,Robbins, T. W.(1993).Contrasting mechanisms of impaired attentional set-shifting in patients with frontal lobe damage or Parkinson's disease.Brain,116(Pt5),1159-75.
  98. Polymeropoulos, M. H.,Lavedan, C.,Leroy, E.,Ide, S. E.,Dehejia, A.,Dutra, A.,Nussbaum, R. L.(1997).Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.Science,276(5321),2045-2047.
  99. Price, J. C.,Kleenk, W. E.,Lopresti, B. J.,Lu, X.,Hoge, J. A.,Ziolko, S. K.,Mathis, C. A.(2005).Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh compound-β.Journal Cerebral Blood flow metabolism,25(11),1528-1547.
  100. Rahkonen, T.,Eloniemi-Sulkava, U.,Rissanen, S.,Vatanen, A.,Viramo, P.,Sulkava, R.(2003).Dementia with Lewy bodies according to the consensus criteria in a general population aged 75 years or older.Journal of Neurology, Neurosurgery, and Psychiatry,74(6),720-724.
  101. Ramakrishnan, M.,Jensen, P. H.,Marsh, D.(2003).Alpha-synuclein association with phosphatidylglycerol probed by lipid spin labels.Biochemistry,42(44),12919-12926.
  102. Ridha, B. H.,Josepha, K. A.,Rossor, M. N.(2005).Delusions and hallucinations in dementia with Lewy bodies: Worsening with memantine.Neurology,65(3),481-482.
  103. Rodriguez-Fernandez, A.,Gomez-Rio, M.,Carnero, C.(1998).Regional cerebral blood flow in patients with dementia with Lewy bodies.Neurobiology Aging,19,S205.
  104. Rowe, C. C.,Ng, S.,Ackermann, U.,Gong, S. J.,Pike, K.,Savage, G.,Villemagne, V. L.(2007).Imaging beta-amyloid burden in aging and dementia.Neurology,68(20),1718-1725.
  105. Sabbagh, M. N.,Hake, A. M.,Ahmed, S.,Farlow, M. R.(2005).The use of memantine in dementia with Lewy bodies.Journal of Alzheimer's Disease,7(4),285-289.
  106. Salmon, D. P.,Galasko, D.,Hansen, L. A.,Masliah, E.,Butters, N.,Thal, L. J.,Katzman, R.(1996).Neuropsychological deficits associated with diffuse Lewy body disease.Brain and Cognition,31(2),148-165.
  107. Sano, M.,Stern, Y.,Williams, J.,Cote, L.,Rosenstein, R.,Mayeux, R.(1989).Coexisting dementia and depression in Parkinson's disease.Archives of Neurology,46(12),1284-1286.
  108. Senard, J. M.,Rai, S.,Lapeyre-Mestre, M.,Brefel, C.,Rascol, O.,Rascol, A.,Montastruc, J. L.(1997).Prevalence of orthostatic hypotension in Parkinson's disease.Journal of Neurology Neurosurgery and Psychiatry,63,584-589.
  109. Sharon, R.,Bar-Joseph, I.,Mirick, G. E.,Serhan, C. N.,Selkoe, D. J.(2003).Altered fatty acid composition of dopaminergic neurons expressing alpha-synuclein and human brains with alpha-synucleinopathies.Journal of Biological Chemistry,278(50),49874-49881.
  110. Shimizu, S.,Hanyu, H.,Kanetaka, H.,Iwamoto, T.,Koizumi, K.,Abe, K.(2005).Differentiation of dementia with Lewy bodies from Alzheimer's disease using brain SPECT.Dementia Geriatric Cognitive Disorder,20(1),25-30.
  111. Spillantini, M. G.,Divane, A.,Goedert, M.(1995).Assignment of human alpha-synuclein (SNCA) and beta-synuclein (SNCB) genes to chromosomes 4q21 and 5q35.Genomics,27(2),379-381.
  112. Stevens, T.,Livingston, G.,Kitchen, G.,Manela, M.,Walker, Z.,Katona, C.(2002).Islington study of dementia subtypes in the community.British Journal of Psychiatry,180,270-276.
  113. Tobe, T.,Nakajo, S.,Tanaka, A.,Mitoya, A.,Omata, K.,Nakaya, K.,Nakamura, Y.(1992).Cloning and characterization of the cDNA encoding a novel brain-specific 14-kDa protein.Journal of Neurochemistry,59(5),1624-1629.
  114. Touchon, J.,Bergman, H.,Bullock, R.,Rapatz, G.,Nagel, J.,Lane, R.(2006).Response to rivastigmine or donepezil in Alzheimer's patients with symptoms suggestive of concomitant Lewy body pathology.Current Medical Reseach Opinion,22(1),49-59.
  115. Tsuboi, Y.,Dickson, D. W.(2005).Dementia with Lewy bodies and Parkinson's disease with dementia: Are they different.Parkinsonism and Related Disorders,11(S1),S47-S51.
  116. Verhoeff, N. P.,Wilson, A. A.,Takeshita, S.,Trop, L.,Hussey, D.,Singh, K.,Houle, S.(2004).In-vivo imaging of Alzheimer's disease beta-amyloid with 〔11C〕-SB13PET.American Journal Geriatric Psychiatry,12(6),584-595.
  117. Walker, Z.,Graces, J.,Overshot, R.,Satarasinghe, S.,Swan, A.,Katona, C. L.,McKeith, I. G.(1999).Olanzapine in dementia with Lewy bodies: A clinical study.International Journal of Geriatric Psychiatry,14(6),459-466.
被引用次数
  1. 廖炎智,程維德,李政育,吳哲豪(2015)。探討育生補陽還五湯加方用於治療巴金森氏病的療效研究。中國鍼灸學雜誌，3(1)，18-46。
  2. 葉瓊鈺,陳富滿,陳玟均,張凱茗,張倩蜜,康宜靜,林哲瑋,呂郁蕙,吳信宏,王釧如,王文甫(2019)。利用Apriori演算法探討失智症患者於照護者壓力之影響：以中部醫學中心為例。品質學報，26(6)，395-418。
print cancel